top of page
Executive Spotlights

Cagent Vascular appoints Brian Walsh as CEO

Wayne, PA, May 7, 2024 (Business Wire) -- Brian Walsh, previously at Carl Zeiss, has been appointed as the new Chief Executive Officer at Cagent Vascular. His extensive experience in the medical device and healthcare industry positions him well to drive Cagent Vascular’s flagship product, Serranator.


Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma

Comments


Life Science Headlines
bottom of page